Input your search keywords and press Enter.

Here’s How Much Pfizer Will Earn From Coronavirus Vaccine Sales in 2021

Pfizer will earn $15 billion from sales of its Coronavirus vaccine developed in collaboration with BioNTech.

The American pharmaceutical company forecasts $59.4 billion and $61.4 billion revenue in 2021 and expects a quarter of its total revenue this year to come from the sales of its COVID-19 vaccine.


Here is How Govt. Plans to Vaccinate All Citizens Before The End of 2021

During an interview, CEO Pfizer, Albert Bourla, said that the company is on track to produce 2 billion doses of Coronavirus vaccines this year which will see it earn $15 billion.

We’ve increased the batches we run per week, we’ve doubled the output – the yield per batch – we’ve dramatically improved our success rates, we’ve made process improvements to the assembly lines.


Govt. to Store Coronavirus Vaccine Doses at High-Security Facilities

Albert Bourla added that Pfizer could exceed the $15 billion mark if the company signs more supply contracts.

Besides, Pfizer has launched a study to determine whether a third dose of its mRNA-based Coronavirus vaccine, administered 6-12 months after the first two doses which are injected three weeks apart, can increase the immunity against the more infectious variants of Coronavirus reported across the world.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *